Paper Details

  1. Home
  2. Paper Details

DSP-6952, a novel 5-HT<sub>4</sub> receptor partial agonist, inhibits visceral hypersensitivity and ameliorates gastrointestinal dysfunction in experimental animals.

Author: AsadaReiko, ItakuraTomohiro, MineYukiko, OkuSeiko, ShimizuIsao

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

DSP-6952, a novel 5-HT<sub>4</sub> receptor partial agonist, has shown promise as a treatment for GI disorders. It enhanced gastric motility, increased defecation without causing diarrhea, and inhibited visceral hypersensitivity in experimental animals.
Paper Details　
Original Abstract of the Article :
The pharmacological profile of DSP-6952, a novel 5-HT<sub>4</sub> receptor partial agonist, was investigated to evaluate the potential use for GI disorders, and to compare its effects in some GI dysfunction models with those of clinically efficacious prokinetic agents. DSP-6952 enhanced gastric moti...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.ejphar.2018.02.005

データ提供：米国国立医学図書館（NLM）

DSP-6952: A Potential Oasis in the Desert of Gastrointestinal Disorders

The desert of gastrointestinal disorders is a complex and often uncomfortable landscape to navigate. This study investigates the potential of DSP-6952, a novel 5-HT4 receptor partial agonist, as a treatment for gastrointestinal dysfunction. It's like discovering a new and promising well of water in a parched desert.

DSP-6952: A Potential Solution for Gastrointestinal Discomfort

The study found that DSP-6952 effectively enhanced gastric motility and improved colonic transit, offering potential relief from gastrointestinal symptoms. It's like finding a smooth and well-paved road through a rugged desert terrain. The researchers suggest that DSP-6952 could be a promising therapeutic agent for conditions like IBS-C and chronic constipation.

Navigating the Desert of Gastrointestinal Health: A New Path Forward

This research provides hope for individuals grappling with gastrointestinal disorders. It's like discovering a hidden oasis in the desert, offering a chance for relief and improved quality of life. Further research is needed to fully understand the efficacy and safety of DSP-6952, but it represents a significant step forward in the quest for effective treatments for gastrointestinal dysfunction.

Dr. Camel's Conclusion

The desert of gastrointestinal disorders is vast and complex, but DSP-6952 appears to be a promising oasis, offering potential relief from a range of gastrointestinal symptoms. It's a reminder that even in the most challenging terrains, there is always hope for finding a solution.

Date :
  1. Date Completed 2018-09-10
  2. Date Revised 2018-09-10
Further Info :

Pubmed ID

29428470

DOI: Digital Object Identifier

10.1016/j.ejphar.2018.02.005

Related Literature

Article Analysis
・Effects of prucalopride
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.